Clinical Practice Session
Success Stories in Glomerular Diseases: From Bench to Bedside, Including the Celeste Castillo Lee Endowed Lectureship
November 06, 2025 | 10:30 AM - 12:30 PM
Location: General Assembly A, Convention Center
Session Description
This session reviews advances in the understanding of glomerular disease pathophysiology and how these advances have been translated to new therapies.
ASN gratefully acknowledges Travere Therapeutics and several of Celeste's family members, friends, and colleagues for support of the Lee Endowed Lectureship.
Learning Objective(s)
- Describe the pathophysiology and treatment of lupus nephritis
- Describe the pathophysiology and treatment of IgAN
- Describe the pathophysiology and treatment of atypical hemolytic uremic syndrome and C3 glomerulopathy
- Describe the pathophysiology and treatment of ANCA-associated vasculitis
Learning Pathway(s)
- Glomerular Diseases
Moderators
Presentations
- Importance of Patient Advocate Partners to Get Discoveries to the Bedside: The Celeste Castillo Lee Endowed Lectureship
10:30 AM - 11:00 AM
- Lupus Nephritis
11:00 AM - 11:30 AM
- Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
11:30 AM - 12:00 PM
- ANCA-Associated Vasculitis
12:00 PM - 12:30 PM